SCHEMBL6401145

SCHEMBL6401145

COc1ccc([C@H]2NC(=O)N(C(N)=O)C2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 2/20 0.47
TP53 P04637 1/20 0.47
GAA P10253 3/20 0.43
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MMP1 P03956 1/20 0.42
MMP13 P45452 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
PARP1 P09874 1/20 0.41
PARP10 Q53GL7 1/20 0.41
PARP2 Q9UGN5 1/20 0.41
PARP4 Q9UKK3 1/20 0.41
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6404733 1.00 ALDH1A1 (0.47) ALDH1A1KDM4ETP53GAACYP2C9
SCHEMBL6399674 0.80 LMNA (0.50) ALDH1A1
SCHEMBL6401309 0.80 LMNA (0.50) ALDH1A1
SCHEMBL6401149 0.78 KDM4E (0.48) ALDH1A1KDM4ETP53GAAMAOA
SCHEMBL6404736 0.78 KDM4E (0.48) ALDH1A1KDM4ETP53GAAMAOA
SCHEMBL8769410 0.76 THRB (0.53) ALDH1A1KDM4ETP53GAATHRB
SCHEMBL31312577 0.71 MAP2K1 (0.48) ALDH1A1KDM4ETP53CYP2C9CYP2C19
SCHEMBL10536959 0.70 KDM4E (0.56) ALDH1A1KDM4ETP53GAAMMP1
SCHEMBL6137174 0.70 ALDH1A1 (0.44) ALDH1A1KDM4ETP53GAACYP2C9
SCHEMBL8209566 0.68 POLB (0.45) ALDH1A1GAAMMP1MMP13MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 ALDH1A1 408/4885KDM4E 1617/4885TP53 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.